Oculis Holding AG (OCS) Exchange Rate Effect (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Exchange Rate Effect of $619347.3 in Q1 2026, up 6287.68% quarter-over-quarter from -$10009.4 in Q4 2025, and up 146.48% on a YoY basis from $251275.9 in Q1 2025.
Oculis Holding AG (OCS) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Oculis Holding AG's Exchange Rate Effect history runs 5 years deep, the most recent figure standing at $619347.3 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 146.48% year-over-year to $619347.3; the TTM figure through Mar 2026 stood at -$5.3 million (down 147.62% YoY), while the FY2025 annual figure was -$7.6 million, down 1731.69% from the prior year.
- Exchange Rate Effect was $619347.3 for Q1 2026 at Oculis Holding AG, up from -$10009.4 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.7 million in Q3 2023 to a low of -$5.7 million in Q2 2025.
- Historically, Exchange Rate Effect has averaged -$640262.8 across 5 years, with a median of -$327314.9 in 2024.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect jumped 1878.16% in 2023, then tumbled 1653.63% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$446349.4 in 2022, then tumbled by 291.23% to -$1.7 million in 2023, then jumped by 154.98% to $960019.9 in 2024, then sank by 101.04% to -$10009.4 in 2025, then soared by 6287.68% to $619347.3 in 2026.
- The last three Exchange Rate Effect figures came in at $619347.3 (Q1 2026), -$10009.4 (Q4 2025), and -$126261.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 8.68 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 619,347.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 619,347.27 |
| Mar 31, 2026 | 619,347.27 |
| Dec 31, 2025 | -10,009.36 |
| Dec 31, 2025 | -10,009.36 |
| Sep 30, 2025 | -126,261.06 |
| Sep 30, 2025 | -126,261.06 |
| Jun 30, 2025 | -5.74 Mn |
| Jun 30, 2025 | -5.74 Mn |
| Mar 31, 2025 | -1.33 Mn |
| Mar 31, 2025 | -1.33 Mn |
| Dec 31, 2024 | 960,019.87 |
| Dec 31, 2024 | 960,019.87 |
| Sep 30, 2024 | -1.42 Mn |
| Sep 30, 2024 | -1.42 Mn |
| Jun 30, 2024 | -327,314.87 |
| Jun 30, 2024 | -327,314.87 |
| Mar 31, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Dec 31, 2023 | -1.75 Mn |